Comparison ImmunityBio (IBRX) with Competitors
ImmunityBio (IBRX) industry is Biotechnology.
Operating Margin
IBRX-157.90%
Industry-2055.25%
Upside+1897.35%
Debt-to-Equity
IBRX-0.10%
Industry28.27%
Upside-28.37%
Free Cash Flow Yield
IBRX-3.69%
Industry-1.75%
Upside-1.95%
P/E
IBRX-9.26
Industry-20.52
Upside+1125.72%
P/S
IBRX57.87
Industry10.01
Upside+477.92%